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	 N‐phenylsulphonyloxytetrachlorophthalimide	 was	 obtained	 by	 treatment	 of	 N‐hydroxy
tetrachlorophthalimide	 with	 benzenesulphonyl	 chloride.	 Also,	 the	 titled	 compound	 3	 was
obtained	 by	 reaction	 of	 compound	 2	 with	 hydrazine	 hydrate	 via	 Lossen	 rearrangement.
Compound	 3	 used	 as	 starting	 material	 for	 the	 synthesis	 of	 new	 pyrimidine	 and
quinazolinedione	 derivatives	 containing	 four	 chlorine	 atoms	 which	 have	 pharmacological
activity.	
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1.	Introduction	
	
Owing	 to	 the	 importance	 of	 tetrachlorophthalimides	 as	
good	α‐glucosides	inhibitors	that	decrease	glucose	level	[1,2]	in	
blood	and	their	use	as	potentially	valuable	for	various	diseases,	
we	 aimed	 in	 the	 present	 study	 to	 synthesize	 another	 class	 of	
new	 tetrachloroheterocyclic	 compounds	 such	 as	 tetrachloro	
quinazolindione	 derivatives.	 It	 has	 been	 recently	 shown	 that	
pyrimidines	 and	 quinazolindiones	 are	 important	 compounds	
posses	 pharmacological	 activity	 including	 use	 as	 anticonvul‐
sant,	electroshock,	pentylenetetrazole	induced	seizures	in	mice	
[3],	 sedative,	 hypotensive	 [4],	 antinflammatory,	 antigonisys	
[5,6],	vasodilator	[7‐9],	contractile	smooth	muscles	and	posses	
inhibitory	activity	 toward	 the	 calcium	 independent	phosphor‐
diesteras	 enzyme	 [10].	 This	 encouraged	 us	 to	 synthesize	
quinazolinedione	derivatives	containing	four	chlorine	atoms	in	
benzene	 ring	 starting	 with	 tetrachlorophthalic	 anhydride	
which	may	possess	greater	certain	pharmacological	activities.	
	
2.	Experimental	
	
2.1.	Instrumentation	
	
Melting	points	were	uncorrected	determined	on	an	electric	
melting	 point	 apparatus	 (Kofler).	 The	 IR	 spectra	 (KBr)	 were	
recorded	 on	 a	 Shimadzu	 408	 spectrometer.	 The	 1H	 NMR	
spectra	 were	 recorded	 by	 200	 MHz	 varian	 EM	 390	
spectrometer;	chemical	shifts	are	reported	in	ppm	with	TMS	as	
an	 internal	standard	and	are	given	 in	δ	units.	Electron	 impact	
mass	 spectra	were	 obtained	 at	 70	 eV	 using	 a	 GC‐MS	 sp.1000	
Shimadzu.	 Elemental	 analyses	 were	 carried	 out	 at	
Microanalysis	Unit	at	Cairo	University;	purity	of	the	compounds	
was	detected	by	TLC.		
	
	
2.2.	Synthesis	
	
2.2.1.	N‐phenylsulphonyloxytetrachlorophthalimide	(2)	
	
Benzenesulphonyl	 chloride	 was	 added	 dropwisely	 with	
stirring	 in	 ice	 bath	 to	 a	 solution	 of	 N‐hydroxytetrachloro	
phthalimide	 (6.3	 g,	 20	 mmol)	 in	 pyridine	 (15	 mL)	 [11].	 The	
reaction	mixture	was	 vigorously	 stirred	 for	 15	min.,	 the	 solid	
formed	was	 acidified	with	 cold	 dilute	 hydrochloric	 acid	 (1:1),	
and	 the	 solid	 formed	 was	 filtered	 off	 and	 dried.	 The	 target	
product	 was	 crystallized	 from	 petroleum	 ether	 (80‐100)	 and	
benzene	(3:1)	to	give	N‐phenylsulphonyloxytetrachlorophthal‐
imide	 (3	 g,	 6.8	 mmol)	 2	 in	 yield	 35	 %	 as	 yellow	 crystals	
(Scheme	 1).	 M.p.:	 244	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1808	 and	 1750	
(C=O),	 1360	 and	 1180	 (SO2‐O‐).	 1H	NMR	 (300	MHz,	DMSO‐d6,	
ppm):	 7.70‐	 8.11	 (m,	 5H,	 Ph‐SO2).	MS	 (m/z,	%):	 439	 (1.01%)	
correspond	 to	 the	 molecular	 formula	 (C14H5Cl4NO5S)	 in	
addition	to	 the	characteristic	peaks	 for	compounds	containing	
four	 chlorine	 atoms	 [13]	 at	 (M+2),	 (M+4)	 and	 (M+6).	 Anal.	
calcd.	 for	 C14H5Cl4NO5S:	 C,	 38.12;	 H,	 1.14;	 N,	 3.18.	 Found:	 C,	
38.31;	H,	1.16;	N,	3.18%.	
	
2.2.2.	3‐aminotetrachloroquinazolin‐2,4‐dione	(3)	
	
A	mixture	of	N‐phenylsulphonyloxytetrachlorophthalimide,	
2,	 (4.41	 g,	 10	mmole)	 and	 hydrazine	 hydrate	 in	 dry	 benzene	
(40	 mL)	 using	 Dean	 &	 starks'	 apparatus	 was	 refluxed	 for	 2	
hours	[12].	After	cooling;	the	solid	formed	was	filtered	off	and	
crystallized	 from	water	 to	 give	 3‐aminotetrachloroquinazolin‐
2,4‐dione	 (2.4	 g,	 7.6	mmole)	3	 in	yield	 76	%	 as	white	 crystal	
(Scheme	2).	M.p.:	 274	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 3457	 (NH),	 3313	
and	 3206	 (NH2),	 1726	 and	 1675	 (C=O).	 1H	 NMR	 (200	 MHz,	
DMSO‐d6,	 ppm):	 5.62	 (s,	 2H,	 NH2)	 and	 also	 showed	 the	
disappearance	 of	NH	signal	 in	DMSO‐d6	while	 FT‐IR	 spectrum	
revealed	the	presence	of	a	band	for	νNH	at	3457	cm‐1.		
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Scheme	2
	
	
Anal.	calcd.	for	C8H3Cl4N3O2:	C,	30.52;	H,	0.96;	N,	13.34.	Found:	
C,	30.75;	H,	0.97;	N,	13.34	%.	
	
2.2.3.	3‐(N‐acetylamino)tetrachloroquinazolin‐2,4‐dione	(4)	
	
To	a	 solution	of	3‐aminotetrachloroquinazolin‐2,4‐dione	3	
(0.315	 g,	 1	 mmole)	 in	 dry	 pyridine	 (10	 mL),	 acetylchloride							
(1	 mL)	 was	 added	 drop	 wisely	 at	 room	 temperature.	 The	
reaction	mixture	was	stirred	for	2	hours,	and	a	cold	diluted	HCl	
(1:1)	was	added	 to	 the	 reaction	mixture	and	 the	 solid	 formed	
was	 filtered	off	 and	crystallized	 from	benzene/ethanol	 to	give	
3‐(N‐acetylamino)tetrachloroquinazolin‐2,4‐dione	(0.29	g,	0.81	
mmole)	4	in	yield	81	%	as	white	crystal	(Scheme	3).	M.p.:	306	
oC.	FT‐IR	(KBr,	cm‐1):	3200	(NH),	1780	and	1750	(C=O)	(imide	
carbonyl).	1H	NMR	(200	MHz,	DMSO‐d6,	ppm):	1.93	(s,	3H,	CH3),	
10.6	(S,	1H,	NH),	11.4	(S,	1H,	NH).	Anal.	calcd.	for	C10H5Cl4N3O3:	
C,	33.65;	H,	1.41;	N,	11.77.	Found:	C,	33.86;	H,	1.42;	N,	11.98%.	
	
2.2.4.	3‐(phenylsulphonylamino)tetrachloroquinazolin‐2,4‐
dione	(5)	
	
3‐aminotetrachloroquinazolin‐2,4‐dione	 3	 (0.31	 g,	 1	
mmole)	 in	 dry	 pyridine	 (10	 mL)	 was	 cooled	 in	 ice	 bath;	
benzenesulphonyl	 chloride	 was	 added	 drop	 wisely.	 The	
reaction	mixture	with	stirred	at	room	temperature	for	4	hours.	
A	cold	diluted	HCl	(1:1)	was	added	to	the	reaction	mixture	and	
the	 solid	 formed	 was	 filtered	 off	 and	 crystallized	 from	
benzene/ethanol	to	give	3‐(phenylsulphonylamino)tetrachloro	
quinazolin‐2,4,dione	 (0.27	 g,	 0.59	mmole)	5	 in	 yield	 59	%	 as	
yellow	crystal	(Scheme	3).	M.p.:	300	oC.	FT‐IR	(KBr,	cm‐1):	3200	
(NH),	1810,	1750	(C=O),	1360,	1180	(SO2).	1H	NMR	(200	MHz,	
DMSO‐d6):	 7.30‐7.90	 (m,	5H,	Ar‐H),	9.75	 (s,	1H,	NH),	11.40	 (s,	
1H,	 NH).	 Anal.	 Calcd.	 for	 C14H7Cl4	 N3O4S.	 C,	 36.95;	 H,	 1.55;	 N,	
9.23.	Found:	C,	37.23;	H,	1.56;	N,	9.34	%.	
	
2.2.5.	3‐(2‐thiophenecarbonylamino)tetrachloroquinazolin‐
2,4‐dione	(6)	
	
A	 solution	 of	 3‐aminotetrachloroquinazolin‐2,4‐dione	 3	
(0.31	 g,	 1	mmole)	 in	 dry	 pyridine	 (10	mL)	was	 cooled	 in	 ice	
bath;	 2‐thiophenecarbonyl	 chloride	 was	 added	 drop	 wisely	
with	stirring	for	4	hours.	A	cold	diluted	HCl	(1:1)	was	added	to	
the	reaction	mixture	and	the	solid	formed	was	filtered	off	and	
crystallized	 from	 benzene/ethanol	 to	 give	 3‐(2‐thiophene‐
carbonylamino)tetrachloroquinazolin‐2,4‐dione	 (0.28	 g,	 0.729	
mmole)	6	in	yield	67	%	as	white	crystal	(Scheme	3).	M.p.:	308	
oC.	FT‐IR	(KBr,	cm‐1):	3200	(NH),	1740	and	1680	(C=O).	1H	NMR	
(200	MHz,	DMSO‐d6,	ppm):	7.26‐7.28	(dd,	1H,	HX),	7.96	(dd,	1H,	
HM),	7.98‐8.02	(dd,	1H,	HA),	11.34	(s,	1H,	NH),	11.55	(s,	1H,	NH).	
MS	 (m/z,	 %):	 423	 (0.59	 %)	 (M+)	 in	 addition	 to	 the	
characteristic	 peaks	 for	 compounds	 containing	 four	 chlorine	
atoms	at	m/z	=	425	(0.66	%)	(M+2),	427	(0.41	%)	(M+4)	and	
429	(0.08	%)	(M+6).	Anal.	calcd.	for	C13H5Cl4N3O3S:	C,	36.74;	H,	
1.18;	N,	9.88.	Found:	C,	36.98;	H,1.19;	N	10.05	%.		
	
2.2.6.	3‐(2‐chloromethylcarbonylamino)tetrachloro	
quinazolin‐2,4‐dione	(7)	
	
To	 a	 stirred	 solution	of	 3‐aminotetrachloroquinazolin‐2,4‐
dione	3	(0.31	g,	1	mmole)	in	DMF	(10	mL),	chloroacetylchloride	
(1	 mL)	 was	 added	 drop	 wisely	 at	 room	 temperature.	 The	
reaction	mixture	was	stirred	for	2	hours,	and	then	dilute	with	
cold	water.	 The	 solid	 formed	was	 filtered	 off	 and	 crystallized	
from	 benzene/ethanol	 to	 give	 3‐(2‐chloromethylcarbonyl‐
amino)tetrachloroquinazolin‐2,4‐dione	(0.35	g,	0.89	mmole)	7	
in	yield	89	%	as	white	crystal	 (Scheme	3).	M.p.:	320	 oC.	FT‐IR	
(KBr,	cm‐1):	3211	(NH),	3021	(CH	Aliph.),	1741	and	1700	(C=O).	
1H	NMR	 (200	MHz,	DMSO‐d6,	ppm):	4.04	 (s,	 2H,	CH2),	 11.2	 (s,	
1H,	 NH),	 11.58	 (s,	 1H,	 NH).	 Anal.	 calcd.	 for	 C10H4Cl5N3O3:	 C,	
30.69;	H,	1.03;	N,	10.73.	Found:	C,	30.81;	H,	1.02;	N	10.90%.	
	
2.2.7.	3‐(N‐benzamido)tetrachloroquinazolin‐2,4‐dione	(8a)	
	
A	 solution	 of	 3‐aminotetrachloroquinazolin‐2,4‐dione	 3	
(0.31	 g,	 1	mmole)	 in	 dry	 pyridine	 (10	mL)	was	 cooled	 in	 ice	
bath;	benzoylchloride	was	added	drop	wisely	with	stirring	for	4	
hours.	 A	 cold	 diluted	 HCl	 (1:1)was	 added	 to	 the	 reaction	
mixture	and	 the	 solid	 formed	was	 filtered	off	 and	crystallized	
from	 benzene/ethanol	 to	 give	 3‐(N‐benzamido)tetrachloro	
quinazolin‐2,4‐dione	(0.32	g,	0.76	mmole)	8a	 in	yield	78	%	as	
white	crystal	(Scheme	3).	M.p.:	310	oC.	FT‐IR	(KBr,	cm‐1):	3200	
(NH),	 3000	 (CH	 arom.),	 1740	 and	 1660	 (C=O).	 1H	 NMR	 (200	
MHz,	 DMSO‐d6,	 ppm):	 7.30‐8.00	 (m,	 5H,	 Ar‐H),	 11.30	 (s,	 1H,	
NH),	11.40	(s,	1H,	NH).	Anal.	calcd.	for	C15H7Cl4N3O3.	C,	42.99;	H,	
1.68;	N,	10.03.	Found:	C,	43.20;	H,	1.66;	N	10.07%.	
	
2.2.8.	3‐[(N‐(4‐bromobenzamido)tetrachloroquinazolin‐2,4‐
dione	(8b)	
	
A	 mixture	 of	 3‐aminotetrachloroquinazolin‐2,4‐dione	 3	
(0.31	 g,	 1	 mmole)	 and	 p‐bromobenzoylchloride	 (0.21	 g,	 1	
mmole)	 in	 dry	 pyridine	 (10	mL)	was	 heated	 under	 reflux	 for	
1/2	hour.	After	 cooling,	 the	 reaction	mixture	was	poured	 into	
cold	 diluted	 HCl	 (1:1).	 The	 solid	 formed	 was	 filtered	 off	 and	
crystallized	 from	 benzene/ethanol	 to	 give	 3‐[(N‐(4‐bromo	
benzamido)tetrachloroquinazolin‐2,4‐dione	 (0.28	 g,	 0.56	
mmole)	8b	in	yield	56	%	as	white	crystal	(Scheme	3).	M.p.:	314	
oC.		
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FT‐IR	(KBr,	cm‐1):	3200	(NH),	3000	(CH	Arom.),	1740	and	1660	
(C=O).	 1H	 NMR	 (200	 MHz,	 DMSO‐d6,	 ppm):	 7.70‐7.90	 (two	
doublet	4H,	A2B2	Arom.),	10.65	(s,	1H,	NH),	11.47	(s,	1H,	NH).	
Anal.	 calcd.	 for	 C15H6BrCl4N3O3:	 C,	 36.18;	 H,	 1.21;	 N,	 8.44.	
Found:	C,	36.28;	H,	1.22;	N	8.68%.	
	
2.2.9.	3‐arylidineaminotetrachloroquinazolin‐2,4‐diones	
(9a‐d)	
	
3‐Aminotetrachloroquinazolin‐2,4‐dione	 3	 (0.31	 g,																	
1	 mmole)	 was	 heated	 under	 reflux	 for	 10‐12	 hours	 with	 the	
appropriate	 aromatic	 aldehydes	 namely	 benzaldehyde,																
p‐nitrobenzaldehyde,	 p‐chlorobenzaldehyde	 and	
thiophenecarbaldehyde	(1	mmole)	in	absolute	ethanol	(20	mL)	
and	 in	 prescence	 of	 pipridine	 as	 a	 catalyst.	 After	 cooling;	 the	
reaction	 mixture	 was	 filtered	 off	 and	 crystallized	 from	
appropriate	 solvent	 to	 give	 the	 arylidine	 derivatives,	 9a‐d,	
respectively	(Scheme	4).	
3‐(Benzylidene‐amino)‐5,6,7,8‐tetrachloro‐1H‐quinazoline‐
2,4‐dione	(9a):		Yield:	77	%	as	yellow	crystal.	M.p.:	360	oC.	FT‐IR	
(KBr,	 cm‐1):	 3221	 (NH),	 1731,1685	 (C=O).	 1H	NMR	 (200	MHz,	
DMSO‐d6,	ppm):	7.54‐7.95	(m,	5H,	arom.	H),	8.6	(s,	1H,	CH=N),	
11.45	 (s,	 1H,	 NH).	 Anal.	 calcd.	 for	 C15H7Cl4N3O2:	 	 C,	 44.71;	 H,	
1.75;	N,	10.42. Found:	C,	44.94;	H,	1.76;	N	10.59%.	
3‐(Nitrobenzylidene‐amino)‐5,6,7,8‐tetrachloro‐1H‐
quinazoline‐2,4‐dione	 (9b):	 Yield:	 64	 %	 as	 brown	 silky.	 M.p.:	
360	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 3389	 (NH),	 1726,	 1623	 (C=O).	 1H	
NMR	 (200	 MHz,	 DMSO‐d6,	 ppm):	 8.24‐8.42	 (two	 d,	 4H,	 A2B2	
arom.),	 8.93	 (s,	 1H,	 CH=N),	 11.20	 (s,	 1H,	 NH).	 Anal.	 calcd.	 for	
C15H7Cl4N3O2:	 C,	 40.22;	 H,	 1.35;	 N,	 12.51.	 Found:	 C,	 40.51;	 H,	
1.36;	N	12.65	%.	
3‐(Chlorobenzylidene‐amino)‐5,6,7,8‐tetrachloro‐1H‐
quinazoline‐2,4‐dione	 (9c):	Yield:	60	%	as	yellow	crystal.	M.p.:	
272	 oC.	 1H	NMR	 (200	MHz,	DMSO‐d6,	 ppm):	 7.63‐7.90	 (two	d,	
4H,	 A2B2	 arom.),	 8.79	 (s,	 1H,	 CH=N),	 11.4	 (s,	 1H,	 NH).	 Anal.	
calcd.	 for	 C15H6Cl5N3O2:	 C,	 41.19;	 H,	 1.38;	 N,	 9.60.	 Found:	 C,	
41.29;	H,	1.39;	N	9.89%.	
5,6,7,8‐Tetrachloro‐3‐[(thiophen‐2‐ylmethylene)‐amino]‐1H‐
quinazoline‐2,4‐dione	(9d):	Yield:	74	%	as	yellow	crystal.	M.p.:	
320	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 3493	 (NH),	 3108‐3032	 (CH	 aliph),	
1751,	1695	(C=O).	1H	NMR	(200	MHz,	DMSO‐d6):	7.30	(dd,	1H,	
HX),	 7.78	 (dd,	 1H,	 HM),	 7.96	 (dd,	 1H,	 HA),	 8.8	 (s,	 1H,	 CH=N),	
11.22	 (s,	1H,	NH).	Anal.	 calcd.	 for	C13H5Cl4N3O2S	 :	 	 C,	38.17;	H,	
1.23;	N,	10.27.	Found:	C,	38.38;	H,	1.24;	N	10.51%.	
	
2.2.10.	N‐(5,6,‐7,8‐tetrachloro‐2,4‐dioxo‐1,4‐dihydro‐2H‐
quinazolin‐3‐yl)‐malonamic	acid	ethyl	ester	(10)	
	
A	 mixture	 of	 3‐aminotetrachloroquinazolin‐2,4‐dione	 3	
(0.31	 g,	 1	 mmole)	 and	 diethylmalonate	 was	 refluxed	 for	 6	
hours.	After	 cooling;	 the	 reaction	mixture	was	 filtered	off	 and	
crystallized	 from	 benzene/ethanol	 to	 give	 N‐(5,6,7,8‐
tetrachloro‐2,4‐dioxo‐1,4‐di‐hydro‐2H‐quinazolin‐3‐yl)malon‐
amic	acid	ethyl	ester	(0.34	g,	0.75	mmole)	10	in	yield	78	%	as	
white	crystal	(Scheme	4).	M.p.:	310	oC.	FT‐IR	(KBr,	cm‐1):	3200	
(NH),	 1740	 and	 1660	 (C=O).	 1H	 NMR	 (200	 MHz,	 DMSO‐d6,	
ppm):	1.18	(t,	3H,	CH3),	3.50	(s,	2H,	CH2‐CO),	4.13	(q,	2H,	CH2‐
O),	 10.90	 (s,	 1H,	 NH),	 11.44	 (s,	 1H,	 NH).	 Anal.	 calcd.	 for	
C13H9Cl4N3O5:	C,	36.39;	H,	2.11;	N,	9.79.	Found:	C,	36.69;	H,	2.12;	
N	9.98%.	
	
2.2.11.	3‐(ethoxymethylidineamino)tetrachloroquinazolin‐
2,4‐dione	(11)	
	
Triethylorthoformate	 is	 added	 to	 3‐aminotetrachloro	
quinazolin‐2,4‐dione	 3	 (0.31	 g,	 1	 mmole).	 The	 mixture	 was	
refluxed	for	6	hours,	and	then	allowed	to	stand	overnight.	The	
precipitated	 product	 was	 collected	 and	 crystallized	 from	
benzene	 to	 give	 3‐(ethoxymethylidineamino)tetrachloro	
quinazolin‐2,4‐dione	(0.27	g,	0.72	mmole)	11	 in	yield	72	%	as	
yellow	crystal	(Scheme	4).	M.p.:	182	oC.	FT‐IR	(KBr,	cm‐1):	3293	
(NH),	 1741	 and	 1660	 (C=O).	 1H	 NMR	 (200	 MHz,	 DMSO‐d6,	
ppm):	 1.37	 (two	 interfered	 triplets	 for	 the	 two	 isomeric	 CH3	
protons),	 4.39	 two	 quartets	 for	 CH2	 (Z),	 4.55	 for	 CH2	 (E)	 in	
integration	ratio	(2:3),	respectively,	7.98	(s,	1H,	CH	(Z)),	8.20	(s,	
1H,	CH	(E)),	11.22	(s,	1H,	NH).	Anal.	calcd.	for	C11H7Cl4N3O3:	C,	
35.61;	H,	1.90;	N,	11.33.	Found:	C,	35.85;	H,	1.91;	N	11.52%.	
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2.2.12.	N‐phenylthiocarbamoyl‐N‐tetrachloroquinazolin‐2,4‐
dione‐N'‐pheny‐lthiourea	(12)	
	
Heating	of	3‐aminotetrachloroquinazolin‐2,4‐dione	3	(0.31	
g,	1	mmole)	with	phenylisothiocyanate	in	absolute	ethanol	(20	
mL)	under	reflux	for	6	hours	gave	after	cooling	a	solid	product	
which	was	filtered	off	and	crystallized	from	benzene	to	give	N‐
phenylthiocarbamoyl‐N‐tetrachloroquinazolin‐2,4‐dione‐N'‐
phenylthiourea	(0.37	g,	0.62	mmole)	12	in	yield	63	%	as	white	
crystal	(Scheme	4).	M.p.:	210	oC.	FT‐IR	(KBr,	cm‐1):	3231,	3185,	
3129	(NH),	1731	and	1695	(C=O).1H	NMR	(200	MHz,	DMSO‐d6,	
ppm):	6.90‐7.57	(m,	10	H,	aromatic),	9.80	(s,	1H,	HN‐CS),	11.20	
(s,	 1H,	 quinazoline	 NH).	 Anal.	 calcd.	 for	 C22H13Cl4N5O2S2:	 C,	
45.15;	H,	2.24;	N,	11.96.	Found:	C,	45.41;	H,	2.25;	N	12.15%.	
	
2.2.13.	N‐phenyl‐N'‐[(1H,3H)‐5,6,7,8‐tetrachloroquinazolin‐
2,4‐dion‐3‐yl]urea	(13)	
	
When	a	mixture	of	3‐aminotetrachloroquinazolin‐2,4‐dione	
3	(0.31	g,	1	mmole)	and	phenyl	thiocyanate	in	dry	pyridine	(10	
mL)	 was	 refluxed	 for	 10	 hours.	 After	 cooling;	 the	 reaction	
mixture	was	 poured	 into	 ice‐water	 and	 the	 solid	 formed	was	
filtered	off	and	crystallized	 from	benzene	to	give	N‐phenyl‐N'‐
[(1H,3H)‐5,6,7,8‐tetrachloro‐quinazolin‐2,4‐dion‐3‐yl]urea	
(0.25	g,	0.57	mmole)	13	in	yield	57	%	(Scheme	4).	M.p.:	194	oC.	
FT‐IR	 (KBr,	 cm‐1):	 3200	 (NH),	 1740	 and	 1660	 (C=O).1H	 NMR	
(200	MHz,	DMSO‐d6,	ppm):	6.98‐7.50	 (m,	5	H,	 aromatic),	 8.70	
(s,	1H,	NH),	10.90	(s,	1H,	NH),	11.80	(s,	1H,	NH).	Anal.	calcd.	for	
C15H8Cl4N4O3:	 C,	 41.51;	 H,	 1.85;	 N,	 12.91.	 Found:	 C,	 41.78;	 H,	
1.86;	N	13.18%.	
	
2.2.14.	Antibacterial	studies	
	
Sallmonela	typhi,	staphylococcus	aureus,	bacillus	cereus	and	
bacillus	 subtilis	were	 obtained	 from	 the	 Faculty	 of	 Veterinary	
Medicine,	Pathology	Department,	Qena,	Egypt.	All	 the	bacteria	
were	grown	on	the	desired	media	until	the	desired	growth	was	
obtained.	
Disc	diffusion	 test	 [14]:	Whatman	paper	No.	 1	 filter	 paper	
was	 used	 to	 make	 sterile	 disc	 in	 order	 to	 screen	 for	 the	
antibacterial	activity	of	Sallmonela	typhi,	Staphylococcus	aureus,	
Bacillus	 cereus	 and	 Bacillus	 subtilis.	 This	 filter	 paper	 was	
punctured	to	the	shape	of	commercial	antibiotic	disc	and	discs	
were	 autoclaved	 at	 121	 °C	 for	 15	 min.	 The	 suspension	 of	
bacteria	 culture	 was	 prepared	 according	 to	 the	 MacFarland	
standard	 0.5	 and	 was	 lawned	 onto	 the	 Mueiller	 Hinton	 agar	
plates	to	produce	the	bacteria	field.	A	sterile	of	punctured	filter	
papers	was	placed	on	 the	bacteria	 field	by	sterile	 forceps	and	
the	solubilized	extract	then	was	pipetted	out	onto	the	surface	of	
filter	 paper	 on	 the	 bacteria	 field.	 Tetracycline	 and	 DMF	 was	
used	 as	 a	 positive	 and	 negative	 control.	 The	 concentration	 of	
the	 compounds	 tested	 was	 50	 mg/mL.	 Finally,	 the	 plate	 was	
incubated	at	37	°C	and	the	zone	inhibition	is	observed	after	24‐
48	h	and	measured	as	mm.	
	
3.	Results	and	discussion	
	
3.1.	Synthesis	
	
As	 a	 part	 of	 our	 program	 aimed	 to	 synthesize	 new	
pyrimidine	 derivatives	 as	 potential	 pharmaceuticals	 and/or	
agrochemicals,	 we	 report	 here	 the	 synthesis	 of	 new	
tetrachloroheterocyclic	 compounds	 such	 as	 tetrachloro	
quinazolindione	 derivatives.	 Treatment	 of	 N‐hydroxytetra	
chlorophthalimide	 with	 benzenesulphonyl	 chloride	 gave	
compound	 2,	which	 identified	 as	N‐phenylsulphonyloxytetra‐
chlorophthalimide	(Scheme	1).	The	main	fragmentation	routes	
for	compound	2	are	shown	in	Scheme	5.	
Treatment	of	N‐phenylsulphonyloxytetrachlorophthalimide	
2	 with	 excess	 hydrazine	 hydrate	 in	 dry	 benzene	 afforded	 3‐
aminotetrachloroquinazolin‐2,4‐dione,	 3	 (Scheme	 3).	 The	
reaction	 of	 N‐phenylsulphonyloxytetrachlorophthalimide,	 2,	
with	 hydrazine	 may	 proceed	 according	 to	 the	 following	
mechanism	(Scheme	6).		
The	 reaction	 of	 compound	3	with	 different	 acid	 chlorides	
was	 intensively	 investigated.	 Several	 3‐substituted	
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tetrachloroquinazolin‐2,4‐diones,	 4,	 5,	 6,	 7,	 8a	 and	 8b	 were		
prepared	 via	 treatment	 of	 3‐aminotetrachloroquinazolin‐2,4‐
dione	 3	 with	 acid	 chlorides	 namely	 acetylchloride,	 benzene	
sulphonylchloride,	 2‐thiophenecarbonyl‐chloride,	 chloroacetyl	
chloride,	 benzoylchloride	 and	 p‐bromobenzoylchloride	
(Scheme	3).	
The	 reactions	 of	 compound	 3	 with	 different	 aldehydes,	
diethylmalonate,	 triethylorthoformate,	 phenyl	 isothiocyanate	
and	 phenyl	 thiocyanate	were	 intensively	 investigated.	 Several	
3‐arylidineaminotetrachloroquinazolin‐2,4‐diones	 9a‐d	 have	
been	prepared	via	treatment	of	3‐aminotetrachloroquinazolin‐
2,4‐dione,	 3,	 with	 different	 aldehydes,	 namely	 benzaldehyde,									
p‐nitrobenzaldehyde,	 p‐chlorobenzaldehyde	 and	 thiophene	
carbaldehyde	(Scheme	4).	Also,	3‐aminotetrachloroquinazolin‐
2,4‐dione,	 3,	 reacted	 with	 diethylmalonate,	 triethylortho‐
formate,	phenyl	isothiocyanate	and	phenyl	 thiocyanate	to	give	
N‐(5,6,‐7,8‐tetrachloro‐2,4‐dioxo‐1,4‐dihydro‐2H‐quinazolin‐3‐
yl)‐malonamic	 acid	 ethyl	 ester,	 10,	 3‐(ethoxymethylidine‐
amino)tetrachloroquinazolin‐2,4‐dione,	 11,	 N‐phenylthio	
carbamoyl‐N‐tetrachloroquinazolin‐2,4‐dione‐N'‐phenyl‐
thiourea,	 12,	 and	 N‐phenyl‐N'‐[(1H,3H)‐5,6,7,8‐tetrachloro	
quinazolin‐2,4‐dion‐3‐yl]urea,	13,	respectively	(Scheme	4).	
	
	
	
Scheme	5	
	
3.2.	Antibacterial	Assays	
	
The	 compound	 3	 exhibited	 anti‐bacterialactivity	 against	
Staph.	 areus	 (8	 mm),	 Bacillus	 cereus	 (15	 mm)	 and	 Bacillus	
subtilis	(9	mm).	On	the	other	hand	this	compound	didn't	show	
any	 inhibition	 activity	 against	 Salmonella	 typhi.	 This	 may	 be	
due	 to	 four	 chlorine	 [15]	 atoms	 and	 pyrimidine	 ring	 [16‐18].	
The	activity	of	compound	7	 against	all	microorganisms	 tested	
showed	positive	reactions	as	indicated	by	zone	of	inhibition	7,	
9,	18,	10	mm,	respectively,	this	may	be	due	to	and	five	chlorine	
atoms,	 respectively.	 The	 compound	 8a	 showed	 the	 most	
activity	against	bacteria	such	as	Bacillus	Subtilis	(29	mm)	which	
is	2	mm	more	than	the	zone	around	tetracycline	disc	(27	mm);	
this	may	be	due	to	presence	of	(HN‐CO‐Ph).	The	Compound	8b	
has	antimicrobial	effect	due	to	presence	of	bromine	atom	[19].	
The	Compound	9b	has	antimicrobial	effect	due	to	presence	of	
(NO2)	group.	The	compounds	9d	and	10	showed	most	activity	
against	Bacillus	Subtilis	(18	mm	and	19	mm,	respectively).	This	
may	be	due	presence	of	(HN‐CO)	group	in	two	compounds.	
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